Cargando…

Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet

The pathogenesis of non-alcoholic steatohepatitis (NASH) is still unclear and the prevention of the development of hepatocellular carcinoma (HCC) has not been established. We established an atherogenic and high-fat diet mouse model that develops hepatic steatosis, inflammation, fibrosis, and liver t...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Hikari, Takabatake, Riuta, Honda, Masao, Takegoshi, Kai, Yamashita, Taro, Nakamura, Mikiko, Shirasaki, Takayoshi, Sakai, Yoshio, Shimakami, Tetsuro, Nagata, Naoto, Takamura, Toshinari, Tanaka, Takuji, Kaneko, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522259/
https://www.ncbi.nlm.nih.gov/pubmed/28591717
http://dx.doi.org/10.18632/oncotarget.18116
_version_ 1783252134844694528
author Okada, Hikari
Takabatake, Riuta
Honda, Masao
Takegoshi, Kai
Yamashita, Taro
Nakamura, Mikiko
Shirasaki, Takayoshi
Sakai, Yoshio
Shimakami, Tetsuro
Nagata, Naoto
Takamura, Toshinari
Tanaka, Takuji
Kaneko, Shuichi
author_facet Okada, Hikari
Takabatake, Riuta
Honda, Masao
Takegoshi, Kai
Yamashita, Taro
Nakamura, Mikiko
Shirasaki, Takayoshi
Sakai, Yoshio
Shimakami, Tetsuro
Nagata, Naoto
Takamura, Toshinari
Tanaka, Takuji
Kaneko, Shuichi
author_sort Okada, Hikari
collection PubMed
description The pathogenesis of non-alcoholic steatohepatitis (NASH) is still unclear and the prevention of the development of hepatocellular carcinoma (HCC) has not been established. We established an atherogenic and high-fat diet mouse model that develops hepatic steatosis, inflammation, fibrosis, and liver tumors at a high frequency. Using two NASH-HCC mouse models, we showed that peretinoin, an acyclic retinoid, significantly improved liver histology and reduced the incidence of liver tumors. Interestingly, we found that peretinoin induced autophagy in the liver of mice, which was characterized by the increased co-localized expression of microtubule-associated protein light chain 3B-II and lysosome-associated membrane protein 2, and increased autophagosome formation and autophagy flux in the liver. These findings were confirmed using primary mouse hepatocytes. Among representative autophagy pathways, the autophagy related (Atg) 5-Atg12-Atg16L1 pathway was impaired; especially, Atg16L1 was repressed at both the mRNA and protein level. Decreased Atg16L1 mRNA expression was also found in the liver of patients with NASH according to disease progression. Promoter analysis revealed that peretinoin activated the promoter of Atg16L1 by increasing the expression of CCAAT/enhancer-binding-protein-alpha. Interestingly, Atg16L1 overexpression in HepG2 cells inhibited palmitate-induced NF-kB activation and interleukin-6-induced STAT3 activation. We showed that Atg16L1 induced the de-phosphorylation of Gp130, a receptor subunit of interleukin-6 family cytokines, which subsequently repressed phosphorylated-STAT3 (Tyr705) levels, and this process might be independent of autophagy function. Thus, peretinoin prevents the progression of NASH and the development of HCC through activating the autophagy pathway by increased Atg16L1 expression, which is an essential regulator of autophagy and anti-inflammatory proteins.
format Online
Article
Text
id pubmed-5522259
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-55222592017-08-21 Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet Okada, Hikari Takabatake, Riuta Honda, Masao Takegoshi, Kai Yamashita, Taro Nakamura, Mikiko Shirasaki, Takayoshi Sakai, Yoshio Shimakami, Tetsuro Nagata, Naoto Takamura, Toshinari Tanaka, Takuji Kaneko, Shuichi Oncotarget Priority Research Paper The pathogenesis of non-alcoholic steatohepatitis (NASH) is still unclear and the prevention of the development of hepatocellular carcinoma (HCC) has not been established. We established an atherogenic and high-fat diet mouse model that develops hepatic steatosis, inflammation, fibrosis, and liver tumors at a high frequency. Using two NASH-HCC mouse models, we showed that peretinoin, an acyclic retinoid, significantly improved liver histology and reduced the incidence of liver tumors. Interestingly, we found that peretinoin induced autophagy in the liver of mice, which was characterized by the increased co-localized expression of microtubule-associated protein light chain 3B-II and lysosome-associated membrane protein 2, and increased autophagosome formation and autophagy flux in the liver. These findings were confirmed using primary mouse hepatocytes. Among representative autophagy pathways, the autophagy related (Atg) 5-Atg12-Atg16L1 pathway was impaired; especially, Atg16L1 was repressed at both the mRNA and protein level. Decreased Atg16L1 mRNA expression was also found in the liver of patients with NASH according to disease progression. Promoter analysis revealed that peretinoin activated the promoter of Atg16L1 by increasing the expression of CCAAT/enhancer-binding-protein-alpha. Interestingly, Atg16L1 overexpression in HepG2 cells inhibited palmitate-induced NF-kB activation and interleukin-6-induced STAT3 activation. We showed that Atg16L1 induced the de-phosphorylation of Gp130, a receptor subunit of interleukin-6 family cytokines, which subsequently repressed phosphorylated-STAT3 (Tyr705) levels, and this process might be independent of autophagy function. Thus, peretinoin prevents the progression of NASH and the development of HCC through activating the autophagy pathway by increased Atg16L1 expression, which is an essential regulator of autophagy and anti-inflammatory proteins. Impact Journals LLC 2017-05-23 /pmc/articles/PMC5522259/ /pubmed/28591717 http://dx.doi.org/10.18632/oncotarget.18116 Text en Copyright: © 2017 Okada et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Priority Research Paper
Okada, Hikari
Takabatake, Riuta
Honda, Masao
Takegoshi, Kai
Yamashita, Taro
Nakamura, Mikiko
Shirasaki, Takayoshi
Sakai, Yoshio
Shimakami, Tetsuro
Nagata, Naoto
Takamura, Toshinari
Tanaka, Takuji
Kaneko, Shuichi
Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet
title Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet
title_full Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet
title_fullStr Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet
title_full_unstemmed Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet
title_short Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet
title_sort peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet
topic Priority Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522259/
https://www.ncbi.nlm.nih.gov/pubmed/28591717
http://dx.doi.org/10.18632/oncotarget.18116
work_keys_str_mv AT okadahikari peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT takabatakeriuta peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT hondamasao peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT takegoshikai peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT yamashitataro peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT nakamuramikiko peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT shirasakitakayoshi peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT sakaiyoshio peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT shimakamitetsuro peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT nagatanaoto peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT takamuratoshinari peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT tanakatakuji peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet
AT kanekoshuichi peretinoinanacyclicretinoidsuppressessteatohepatitisandtumorigenesisbyactivatingautophagyinmicefedanatherogenichighfatdiet